Abstract

UTERINE FIBROIDS: A REVIEW

Dr. Divya Amaravadi*, Rakham Sneha, Gurnoor Suman, Jajapur Shresta, Bijjaram Malavika, Dr. Rama Rao Tadikonda

.

Abstract

Uterine fibroids (also called as leiomyomas) are mild monoclonal tumors of the myometrium that are the most frequently observed malignancies in women across the world. Due to the lack of understanding of the molecular mechanisms behind the formation and progression of uterine fibroids, there are currently no long-term or noninvasive therapeutic options for hormone-dependent uterine fibroids. Uterine fibroids affect more than 75% of women and can have serious consequences. It has been reported that roughly 30% of women diagnosed with uterine fibroids experience irregular uterine bleeding, which leads to anemia and a lower quality of life worsening their functional and mental state and disrupting sexual function. Reproductive illnesses that involve fibroids in the uterus can cause fertility problems, frequent miscarriage, and poor obstetric outcomes. This article focuses on the occurrence and management of leiomyoma in reproductive women. The recommended surgical approach for the management of uterine fibroids is hysterectomy. Nowadays, conservative therapy is also utilized to treat uterine fibroids and to prepare for surgery. This procedure reduces pain, improves hemoglobin levels, shortens surgery times, and reduces blood loss during the procedure. These findings enable us the inference that the high prevalence and adaptability of uterine fibroids symptoms among individuals of reproductive age require the necessity of looking for the best possible treatment options.

Keywords: Hysterectomy; Leiomyoma; Uterine fibroids.